![]()
|
|
||||||||
Volume 272, Number 47, Issue of November 21, 1997 pp. 29419-29422
B-
Inhibits Its Cleavage by Caspase
CPP32 in Vitro*
(Received for publication, May 29, 1997, and in revised form, September 12, 1997)
§,
,


From the
Department of Biology, Boston University,
Boston, Massachusetts 02215 and the ¶ Howard Hughes Medical
Institute, Department of Biology, Massachusetts Institute of
Technology, Cambridge, Massachusetts 02139
I
B proteins function as direct regulators of
Rel/NF-
B transcription complexes. We show that the cell-death
protease CPP32 (caspase-3) in vitro specifically cleaved
chicken and human I
B-
at a conserved Asp-Ser sequence. This
cleavage site appears to be identical to the site at which chicken
I
B-
is cleaved in vivo in temperature-sensitive
v-Rel-transformed chicken spleen cells undergoing apoptosis. Other
caspases, namely interleukin-1
-converting enzyme (caspase-1) and
Ich-1 (caspase-2), did not cleave I
B-
. CPP32 also cleaved
mammalian I
B-
in vitro at the analogous Asp-Ser sequence. Cleavage of I
B-
by CPP32 was blocked by serine
phosphorylation of I
B-
. Cleavage of I
B-
by a CPP32- like
protease could generate a constitutive inhibitor of Rel transcription
complexes. This report provides evidence for a direct biochemical
interaction between the NF-
B signaling pathway and a cell-death
protease signaling pathway.
Apoptosis is a form of regulated programmed cell death that is
involved in normal development and organ homeostasis (reviewed in Ref.
1). One cellular pathway leading to apoptosis involves a family of
related cysteine proteases (caspases) first defined by the
Caenorhabditis elegans cell-death protease CED-3 and the interleukin-1
-converting enzyme
(ICE)1 (reviewed in Refs. 2
and 3). Although all caspases cleave C-terminal to Asp residues,
individual proteases show distinct substrate specificities in
vitro and can be divided into subfamilies based on substrate
preference (3, 4). The caspase CPP32 shows a substrate specificity
similar to that of CED-3, and CPP32 appears to be an important
cell-death protease in vertebrates. For example, mice with a disruption
of the gene encoding CPP32 have reduced neural cell death (5). It is
likely that in many cell types specific cell-death proteases are
activated in a sequential manner to lead to cell death (6). Thus, one
class of in vivo substrates for the cell-death proteases
includes the caspases themselves. In addition, several other proteins
have been identified as substrates for caspases (reviewed in Ref.
3).
The I
B proteins comprise a conserved family of proteins that act as
regulators of the Rel/NF-
B family of transcription factors (reviewed
in Ref. 7). I
B proteins are structurally related in that they all
have a central core of ankyrin repeats that are essential for
interaction with Rel complexes. Interaction of an I
B protein with a
Rel complex usually results in retention of the Rel complex in the
cytoplasm and inhibition of the DNA binding activity of the Rel
complex.
In the best characterized case, I
B-
interacts with and inhibits
the activity of NF-
B. In response to a variety of signals, I
B-
becomes phosphorylated on two Ser residues in its N-terminal regulatory
domain (8-10). This N-terminal phosphorylation leads to ubiquitination
of I
B-
at nearby Lys residues, thereby targeting I
B-
for
cleavage by the proteasome (11-13). The free NF-
B complex can then
enter the nucleus and affect gene transcription.
We have previously shown that I
B-
undergoes a specific N-terminal
cleavage in chicken spleen cells transformed by a temperature-sensitive mutant of the retroviral oncoprotein v-Rel when these cells are induced
to undergo apoptosis by a shift to the nonpermissive temperature (14).
This observation led us to suggest that I
B-
might be a direct
substrate for a cell-death protease, which could cleave I
B-
at a
conserved Asp near the N terminus (Fig. 1A; Ref. 15).
B-
(p40) by
CPP32. A, shown is the conserved region of signal-induced
serine (bold S) phosphorylation in the indicated I
B
proteins (Hu, human; Ch, chicken; Mu,
murine); relevant amino acid residues are indicated above each
sequence. DEVD is the sequence of a potent inhibitor of CPP32, and the
predicted cleavage site C-terminal to the aspartate residue is
indicated by the arrow. B, specific cleavage of p40 by
CPP32. In vitro translated, radiolabeled p40 was incubated
without (
) or with (+) the indicated proteases. C, p40 was
incubated without (
) or with (+) CPP32 and in the absence (
) or
presence (+) of the tetrapeptide inhibitor Ac-Asp-Glu-Val-Asp-aldehyde
(DEVD). In B and C, samples were
analyzed by SDS-PAGE followed by autoradiography and phosphorimaging,
respectively. The positions of full-length p40 and cleaved p40
(
N) are indicated by arrows.
[View Larger Version of this Image (27K GIF file)]
In this report, we show that I
B-
is a substrate for CPP32
in vitro. Cleavage of I
B-
by CPP32 could create a
dominant inhibitor of Rel transcription complexes.
Chicken spleen cell lines transformed by ts mutant v-G37E were cultured in Temin's modified Eagle's medium containing 20% fetal bovine serum as described previously (14).
Plasmids and in Vitro MutagenesisSite-directed mutagenesis
of p40 was performed using the method of Kunkel (16), as described
previously (17). An EcoRI to HincII fragment from
an I
B-
/p40 cDNA was first subcloned into M13mp19. The
following oligonucleotides were used on single-stranded DNA
templates to create the indicated I
B-
/p40 mutants: D35A, 5
-GACGACCGCCACGCCAGCGGGCTGGAC-3
; D39A,
5
-GACCGCCACGACAGCGGGCTGGCCTCCATG-3
; S36A/S40A,
5
-CGCCACGACGCCGGGCTGGACGCCATGAAG-3
; S36E/S40E,
5
-GACCGCCACGACGAAGGGCTGGACGAACTGAAG-3
. The D35A mutation introduced a
BstXI site that was used in screening for other mutations.
All mutations were confirmed by DNA sequencing.
To create in vitro expression vectors for I
B-
/p40,
human I
B-
, and mouse I
B-
, cDNAs were subcloned into
pGEM4. An EcoRI to HincII fragment containing
wild-type p40 sequences was subcloned into pGEM4 digested with
EcoRI and HincII; expression vectors for mutant
I
B-
/p40 proteins were made by replacing wild-type sequences with
appropriate mutant fragments. Wild-type and D31A human I
B-
inserts were subcloned as KpnI to
NotI/Klenow-treated fragments into pGEM4 digested with
KpnI and HincII. An EcoRI to XhoI fragment from a mouse I
B-
cDNA was subcloned
into pGEM4 digested with EcoRI and SalI.
All in vitro
translations were performed in the TNT-coupled wheat germ extract
(Promega) using SP6 polymerase in the presence of
Tran35S-label (Amersham Corp.). Cleavage of in
vitro translated proteins by individual caspases was performed as
described previously (4). Briefly, in vitro translated
substrate proteins were incubated in CED-3 buffer (50 mM
Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5 mM sucrose, 5% glycerol) with approximately 40 ng of a given bacterially produced and purified enzyme for 2-6 h at 30 or 37°C. Where indicated, the
CPP32 inhibitor Ac-Asp-Glu-Val-Asp-aldehyde (DEVD; Bachem) was included
at a concentration of 50 µM. Phosphorylation of in vitro translated p40 was carried out with purified I
B kinase as
described previously (18). Phosphorylated p40 was dephosphorylated by
treatment with calf intestinal phosphatase (Boehringer Mannheim) for 45 min at 30°C. Samples were separated on SDS-PAGE, and
35S-labeled proteins were detected by autoradiography or
using a phosphorimager (Bio-Rad).
Western blotting was performed as described previously (14) using anti-Rel primary antiserum (1:500) (19) or an anti-p40 monoclonal antibody (anti-ANK; HY95) (1:2500) (14). The appropriate secondary antiserum was added, and complexes were detected by enhanced chemiluminescence (Amersham) and autoradiography.
B-
(p40) Is a Substrate for CPP32 in Vitro
To
determine whether chicken I
B-
(called p40 hereafter) could serve
as a direct substrate of a caspase, in vitro translated p40
was incubated with bacterially expressed and purified ICE, CPP32, and
Ich-1, which represent apparently distinct classes of enzymes within
the caspase family (2, 4). p40 was specifically cleaved by CPP32, but
not by ICE or Ich-1 (Fig. 1B).
Cleavage of p40 in vitro by CPP32 was inhibited by
Ac-Asp-Glu-Val-Asp-aldehyde (DEVD), a specific peptide inhibitor of
CPP32-like proteases (Fig. 1, A and C). Thus, p40
is a substrate of CPP32 in vitro.
CPP32-like
proteases cleave C-terminal to Asp residues that are frequently
followed by Gly, Ser, or Ala and that are often in the consensus
sequence Asp-X-X-Asp-Gly/Ser/Ala (3). There is a potential CPP32 cleavage site
(Asp-Arg-His-Asp-Ser-Gly-Leu-Asp-Ser, aa 32-40; Fig.
1A) between aa 35 and 36 of p40. To determine if this was
the site of CPP32 cleavage in p40, mutants with site-directed changes
in p40 were incubated with CPP32 (Fig. 2,
A and B). Mutant D35A, in which the predicted Asp
cleavage site was changed to an Ala, was not detectably cleaved by
CPP32. In contrast p40 mutant D39A was cleaved by CPP32 to a similar
extent as wild-type p40. The cleaved form of p40 is not recognized by a
monoclonal antibody directed against the N terminus of p40, indicating
that CPP32 cleaved near the N terminus of p40 in vitro (data
not shown; Ref. 14). These results indicate that CPP32 cleaved p40
between Asp-35 and Ser-36.
) and with (+) CPP32. Samples were
separated by SDS-PAGE, and proteins were detected by
autoradiography.
[View Larger Version of this Image (24K GIF file)]
In Vitro Cleaved p40 Co-migrates on SDS-Polyacrylamide Gels with in Vivo Cleaved p40
We previously showed that p40 is cleaved near
its N terminus in chicken spleen cells transformed by ts v-Rel mutant
v-G37E when these cells are induced to undergo apoptosis by a shift to the nonpermissive temperature (14, 15). As shown in Fig.
3, A and B, the
proteolyzed form of p40 generated by in vitro cleavage with
CPP32 co-migrates on SDS-polyacrylamide gels with the major N-terminally truncated form of p40 seen in ts v-Rel-transformed cells
undergoing apoptosis. This result suggests that the N-terminal cleavage
of p40 in vitro by CPP32 is identical to the cleavage of p40
that occurs in ts v-G37E-transformed chicken spleen cells undergoing
apoptosis.
) or with (+)
CPP32. The third lane of this gel contains an unlabeled
lysate from ts v-G37E-transformed spleen cells that had been shifted to
the nonpermissive temperature for 48 h. Samples were transferred
to a filter that was exposed to film directly (A) or probed
by Western blotting with an anti-p40 monoclonal antibody
(B). To equalize the images, the first two lanes
in B are from a longer exposure than in the third
lane. p40 indicates full-length p40;
N indicates the
N-terminally cleaved form of p40.
[View Larger Version of this Image (29K GIF file)]
Phosphorylation at Sites of Signal-induced Phosphorylation Blocks the Ability of Chicken p40 to Serve as a Substrate for CPP32
Ser-36 and Ser-40, which are located just beyond Asp-35
(the site of CPP32 cleavage) in p40, are sites of signal-induced
phosphorylation (8-10). Phosphorylation at these Ser residues can be
mimicked by Glu substitutions at these sites (8), and I
B-
can be
phosphorylated in vitro at these Ser residues by a purified
MEKK1-activated kinase from HeLa cells (18). To determine whether
phosphorylation at these Ser residues affects the ability of p40 to
serve as a substrate for CPP32, we tested whether p40 double mutant
S36E/S40E as well as in vitro phosphorylated p40 could be
cleaved by CPP32 in vitro (Fig.
4). Neither the S36E/S40E mutant nor
wild-type p40 phosphorylated at Ser-36 and Ser-40 in vitro
was cleaved by CPP32. In contrast, p40 mutant S36A/S40A (Ser
Ala)
was cleaved by CPP32 to the same extent as wild-type nonphosphorylated
p40. Treatment of phosphorylated p40 with calf intestinal phosphatase
rendered p40 susceptible to cleavage by CPP32. Taken together, these
results suggest that signal-induced phosphorylation of I
B-
in vivo would block its ability to be cleaved by a
CPP32-like protease(s).
) or with (+) CPP32. B, p40 was
translated in vitro and, where indicated, treated with
MEKK1-activated I
B-
kinase (lanes 3, 4, and
9-12) and/or calf intestinal phosphatase (lanes 7, 8, 11, and 12). The phosphorylated form of p40
(pp40) migrates as a doublet with a slower mobility than
nonphosphorylated p40. As indicated, samples were then incubated
without (
) or with (+) CPP32. All samples were analyzed as described
for Fig. 1.
[View Larger Version of this Image (34K GIF file)]
Other Vertebrate I
B Proteins Can Also Be Cleaved by
CPP32
The Asp-Ser sequence at aa 35-36 of chicken I
B-
/p40
is conserved in mammalian I
B-
and I
B-
(aa 31-32 in human
I
B-
and aa 19-20 in mouse I
B-
; Fig. 1A). To
determine whether these mammalian I
B proteins could also serve as
substrates for CPP32, in vitro translated human I
B-
and mouse I
B-
were incubated with CPP32 (Fig.
5). Each mammalian I
B protein was
cleaved by CPP32 to a size consistent with cleavage at this Asp-Ser
sequence. Furthermore, human I
B-
mutant D31A, containing a
mutation at the predicted Asp cleavage site, was not cleaved by CPP32.
Thus, mammalian I
B proteins can also be cleaved by CPP32 in
vitro.
B proteins by
CPP32. The indicated radiolabeled proteins were incubated without
(
) or with (+) CPP32, and samples were analyzed as described for Fig.
1.
[View Larger Version of this Image (34K GIF file)]
In this report, we describe biochemical evidence for a link
between an apoptosis pathway and the Rel/NF-
B signal transduction pathway. Specifically, we have shown that I
B proteins can serve in vitro as direct substrates for the cell-death protease
CPP32. In addition, the chicken p40 cleavage product generated by
in vitro cleavage with CPP32 appears to be identical to that
generated in vivo in temperature-sensitive v-Rel-transformed
cells undergoing apoptosis (14, 15). CPP32 is expressed in these
cells,2 indicating that CPP32
may be the in vivo cleaving activity; however, we cannot
exclude the possibility that a related protease cleaves p40 in these
cells.
Three observations indicate that cleavage of p40 is not essential for the apoptosis that occurs in ts v-Rel-transformed cells shifted to the nonpermissive temperature. First, cleavage of p40 is a late event in ts v-Rel-transformed spleen cells undergoing apoptosis (14). Second, Bcl-2 blocks apoptosis in these cells but does not block cleavage of p40 (15). Third, CrmA (a cowpox virus-encoded inhibitor of caspases) blocks N-terminal cleavage of p40 in these cells but does not block apoptosis (15).
Our results indicate that cleavage of I
B-
by a CPP32-like
protease is distinct from signal-induced, proteasome-mediated cleavage
of I
B-
. Namely, signal-induced cleavage of I
B-
requires phosphorylation at two N-terminal Ser residues, whereas phosphorylation or mutations that mimic phosphorylation at these Ser residues block the
ability of CPP32 to cleave I
B-
. Therefore, we appear to have
identified a novel pathway for proteolysis of I
B-
.
Overexpression of an N-terminally deleted form of I
B-
, which is
resistant to ubiquitination-based degradation, prevents activation of
NF-
B (20). Therefore, cleavage of I
B-
by a CPP32-like protease
could create what is sometimes called a super-repressor form of
I
B-
(20). That is, cleavage by CPP32 would block the ability of
I
B-
to undergo signal-induced degradation by removing the sites
of signal-induced ubiquitination and by likely disrupting the ability
of I
B-
to become phosphorylated at critical Ser residues.
Therefore, cleavage of I
B-
by CPP32 would block activation of
Rel/NF-
B complexes and their responsive genes.
Activation of the tumor necrosis factor receptor has recently been
shown to induce two conflicting pathways, one leading to CPP32-mediated
apoptosis and one leading to activation of NF-
B, which is
anti-apoptotic (20-23). Inhibition of NF-
B activation by a
noninducible form of I
B-
renders cells more susceptible to tumor
necrosis factor-induced apoptosis (20, 21, 23). Therefore, cleavage of
I
B-
by a CPP32-like protease may act to facilitate, rather than
effect, apoptosis.
Supported by Fellowships from the Anna Fuller Fund and the
Helen Hay Whitney Foundation.

Partially supported by an American Cancer Society Faculty
Research Award. To whom correspondence should be addressed: Boston University, Biology Dept., 5 Cummington St., Boston, MA 02215-2406. Tel.: 617-353-5444; Fax: 617-353-6340; E-mail:
gilmore{at}bio.bu.edu.
-converting enzyme; aa, amino acid(s); PAGE,
polyacrylamide gel electrophoresis.
We thank G. Pitoc for excellent technical
assistance, Drs. D. White and S. Shaham for helpful discussions, K. Lee
for help with plasmid constructions, Drs. T. Maniatis and F. Lee for
generously providing in vitro phosphorylated p40, Drs. D. Baltimore and X. Yang for I
B-
, Dr. M. Karin for human I
B-
and mutant D31A, Drs. C. Li and J. Celenza for help with figures, and
Dr. J.-C. Epinat for help with purification of CPP32.
This article has been cited by other articles:
![]() |
C. Zaragoza, M. Saura, E. Y. Padalko, E. Lopez-Rivera, T. R. Lizarbe, S. Lamas, and C. J. Lowenstein Viral protease cleavage of inhibitor of {kappa}B{alpha} triggers host cell apoptosis PNAS, December 12, 2006; 103(50): 19051 - 19056. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Taggart, S.-A. Cryan, S. Weldon, A. Gibbons, C. M. Greene, E. Kelly, T. B. Low, S. J. O'Neill, and N. G. McElvaney Secretory leucoprotease inhibitor binds to NF-{kappa}B binding sites in monocytes and inhibits p65 binding J. Exp. Med., December 19, 2005; 202(12): 1659 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. CHANG, Y.-T. WANG, and H.-M. CHANG Pectinesterase Inhibitor from Jelly Fig (Ficus awkeotsang Makino) Achene Induces Apoptosis of Human Leukemic U937 Cells Ann. N.Y. Acad. Sci., May 1, 2005; 1042(1): 506 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kato, H. Fukuda, T. Nonaka, and S. Imajoh-Ohmi Cleavage of Nonmuscle Myosin Heavy Chain-A during Apoptosis in Human Jurkat T Cells J. Biochem., February 1, 2005; 137(2): 157 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rathore, H. Matta, and P. M. Chaudhary An Evolutionary Conserved Pathway of Nuclear Factor-{kappa}B Activation Involving Caspase-mediated Cleavage and N-end Rule Pathway-mediated Degradation of I{kappa}B{alpha} J. Biol. Chem., September 17, 2004; 279(38): 39358 - 39365. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Ho, R. E. Ruffin, C. Murgia, L. Li, S. A. Krilis, and P. D. Zalewski Labile Zinc and Zinc Transporter ZnT4 in Mast Cell Granules: Role in Regulation of Caspase Activation and NF-{kappa}B Translocation J. Immunol., June 15, 2004; 172(12): 7750 - 7760. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Connor, S. D. Shumway, I. J. Amanna, C. E. Hayes, and S. Miyamoto Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant I{kappa}B{alpha} Degradation in B Cells Mol. Cell. Biol., June 1, 2004; 24(11): 4895 - 4908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lewis, E. Burstein, S. B. Reffey, S. B. Bratton, A. B. Roberts, and C. S. Duckett Uncoupling of the Signaling and Caspase-inhibitory Properties of X-linked Inhibitor of Apoptosis J. Biol. Chem., March 5, 2004; 279(10): 9023 - 9029. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Nemeth, H. R. Wong, K. Odoms, E. A. Deitch, C. Szabo, E. S. Vizi, and G. Hasko Proteasome Inhibitors Induce Inhibitory {kappa}B (I{kappa}B) Kinase Activation, I{kappa}B{alpha} Degradation, and Nuclear Factor {kappa}B Activation in HT-29 Cells Mol. Pharmacol., February 1, 2004; 65(2): 342 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fluhrer, A. Friedlein, C. Haass, and J. Walter Phosphorylation of Presenilin 1 at the Caspase Recognition Site Regulates Its Proteolytic Processing and the Progression of Apoptosis J. Biol. Chem., January 16, 2004; 279(3): 1585 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Oakley, N. Trim, C. M. Constandinou, W. Ye, A. M. Gray, G. Frantz, K. Hillan, T. Kendall, R. C. Benyon, D. A. Mann, et al. Hepatocytes Express Nerve Growth Factor during Liver Injury: Evidence for Paracrine Regulation of Hepatic Stellate Cell Apoptosis Am. J. Pathol., November 1, 2003; 163(5): 1849 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Esposti, G. Ferry, P. Masdehors, J. A. Boutin, J. A. Hickman, and C. Dive Post-translational Modification of Bid Has Differential Effects on Its Susceptibility to Cleavage by Caspase 8 or Caspase 3 J. Biol. Chem., April 25, 2003; 278(18): 15749 - 15757. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Regula, K. Ens, and L. A. Kirshenbaum IKKbeta Is Required for Bcl-2-mediated NF-kappa B Activation in Ventricular Myocytes J. Biol. Chem., October 4, 2002; 277(41): 38676 - 38682. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Nyormoi, Z. Wang, D. Doan, M. Ruiz, D. McConkey, and M. Bar-Eli Transcription Factor AP-2{alpha} Is Preferentially Cleaved by Caspase 6 and Degraded by Proteasome during Tumor Necrosis Factor Alpha-Induced Apoptosis in Breast Cancer Cells Mol. Cell. Biol., August 1, 2001; 21(15): 4856 - 4867. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, V. Castranova, and X. Shi New Insights into the Role of Nuclear Factor-{kappa}B in Cell Growth Regulation Am. J. Pathol., August 1, 2001; 159(2): 387 - 397. [Abstract] [Full Text] |
||||
![]() |
S. Kreuz, D. Siegmund, P. Scheurich, and H. Wajant NF-{kappa}B Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling Mol. Cell. Biol., June 15, 2001; 21(12): 3964 - 3973. [Abstract] [Full Text] |
||||
![]() |
S. Pampfer, S. Cordi, S. Cikos, B. Picry, I. Vanderheyden, and R. D. Hertogh Activation of Nuclear Factor {kappa}B and Induction of Apoptosis by Tumor Necrosis Factor-{alpha} in the Mouse Uterine Epithelial WEG-1 Cell Line Biol Reprod, September 1, 2000; 63(3): 879 - 886. [Abstract] [Full Text] |
||||
![]() |
S. S. BAE, D. K. PERRY, Y. S. OH, J. H. CHOI, S. H. GALADARI, T. GHAYUR, S. H. RYU, Y. A. HANNUN, and P.-G. SUH Proteolytic cleavage of phospholipase C-{gamma}1 during apoptosis in Molt-4 cells FASEB J, June 1, 2000; 14(9): 1083 - 1092. [Abstract] [Full Text] |
||||
![]() |
S. Schoonbroodt, V. Ferreira, M. Best-Belpomme, J. R. Boelaert, S. Legrand-Poels, M. Korner, and J. Piette Crucial Role of the Amino-Terminal Tyrosine Residue 42 and the Carboxyl-Terminal PEST Domain of I{kappa}B{alpha} in NF-{kappa}B Activation by an Oxidative Stress J. Immunol., April 15, 2000; 164(8): 4292 - 4300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Granville, C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J.-Y. Matroule, J. Piette, and D. W. C. Hunt Nuclear factor-kappa B activation by the photochemotherapeutic agent verteporfin Blood, January 1, 2000; 95(1): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. de Moissac, H. Zheng, and L. A. Kirshenbaum Linkage of the BH4 Domain of Bcl-2 and the Nuclear Factor kappa B Signaling Pathway for Suppression of Apoptosis J. Biol. Chem., October 8, 1999; 274(41): 29505 - 29509. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. FADEEL, B. ZHIVOTOVSKY, and S. ORRENIUS All along the watchtower: on the regulation of apoptosis regulators FASEB J, October 1, 1999; 13(13): 1647 - 1657. [Abstract] [Full Text] |
||||
![]() |
J. Y. Reuther and A. S. Baldwin Jr. Apoptosis Promotes a Caspase-induced Amino-terminal Truncation of Ikappa Balpha That Functions as a Stable Inhibitor of NF-kappa B J. Biol. Chem., July 16, 1999; 274(29): 20664 - 20670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Walter, A. Schindzielorz, J. Grunberg, and C. Haass Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis PNAS, February 16, 1999; 96(4): 1391 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Krishnamoorthy, M. J. Crawford, M. M. Chaturvedi, S. K. Jain, B. B. Aggarwal, M. R. Al-Ubaidi, and N. Agarwal Photo-oxidative Stress Down-modulates the Activity of Nuclear Factor-kappa B via Involvement of Caspase-1, Leading to Apoptosis of Photoreceptor Cells J. Biol. Chem., February 5, 1999; 274(6): 3734 - 3743. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bradham, T. Qian, K. Streetz, C. Trautwein, D. A. Brenner, and J. J. Lemasters The Mitochondrial Permeability Transition Is Required for Tumor Necrosis Factor Alpha-Mediated Apoptosis and Cytochrome c Release Mol. Cell. Biol., November 1, 1998; 18(11): 6353 - 6364. [Abstract] [Full Text] |
||||
![]() |
S. P. Hehner, T. G. Hofmann, F. Ratter, A. Dumont, W. Droge, and M. L. Schmitz Tumor Necrosis Factor-alpha -induced Cell Killing and Activation of Transcription Factor NF-kappa B Are Uncoupled in L929 Cells J. Biol. Chem., July 17, 1998; 273(29): 18117 - 18121. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, R. Gururajan, and V. J. Kidd Phosphorylation of PITSLRE p110 Isoforms Accompanies Their Processing by Caspases during Fas-mediated Cell Death J. Biol. Chem., June 26, 1998; 273(26): 16601 - 16607. [Abstract] [Full Text] [PDF] |
||||
![]() |
|